149 related articles for article (PubMed ID: 4934830)
1. Hemodynamic evaluation of glucagon in symptomatic heart disease.
Armstrong PW; Gold HK; Daggett WM; Austen WG; Sanders CA
Circulation; 1971 Jul; 44(1):67-73. PubMed ID: 4934830
[No Abstract] [Full Text] [Related]
2. Cardiovascular effects of glucagon in man.
Parmley WW; Glick G; Sonnenblick EH
N Engl J Med; 1968 Jul; 279(1):12-7. PubMed ID: 4872564
[No Abstract] [Full Text] [Related]
3. Efficacy of isoproterenol-glucagon infusion in patients with heart disease.
Polumbo RA; Leighton RF; Weissler AM
Circulation; 1971 Jun; 43(6):786-91. PubMed ID: 4325386
[No Abstract] [Full Text] [Related]
4. Hemodynamic effects of glucagon in patients with heart disease.
Williams JF; Childress RH; Chip JN; Border JF
Circulation; 1969 Jan; 39(1):38-47. PubMed ID: 5782807
[No Abstract] [Full Text] [Related]
5. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
Jewitt D; Birkhead J; Mitchell A; Dollery C
Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
[No Abstract] [Full Text] [Related]
6. Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
Diamond G; Forrester J; Danzig R; Parmley WW; Swan HJ
Am J Cardiol; 1971 Jun; 27(6):612-6. PubMed ID: 5092474
[No Abstract] [Full Text] [Related]
7. A role for glucagon in cardiac therapy.
Parmley WW; Sonnenblick EH
Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903
[No Abstract] [Full Text] [Related]
8. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
Reale A; Motolese M; Imhof P
Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
[No Abstract] [Full Text] [Related]
9. [Cardiovascular effects of glucagon].
Lavarenne J
Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
[No Abstract] [Full Text] [Related]
10. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
Nobel-Allen N; Kirsch M; Lucchesi BR
J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394
[No Abstract] [Full Text] [Related]
11. Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock.
Puri PS; Bing RJ
Am Heart J; 1969 Nov; 78(5):660-8. PubMed ID: 5348748
[No Abstract] [Full Text] [Related]
12. Responses of the ischemic myocardium to allopurinol.
DeWall RA; Vasko KA; Stanley EL; Kezdi P
Am Heart J; 1971 Sep; 82(3):362-70. PubMed ID: 4935615
[No Abstract] [Full Text] [Related]
13. Haemodynamic effects of low-dose isoproterenol and aminophylline after coronary embolization in dogs.
Falicov RE; Lipp H; Resnekov L; King S
Cardiovasc Res; 1973 Jan; 7(1):63-8. PubMed ID: 4694958
[No Abstract] [Full Text] [Related]
14. Experimental myocardial infarction. X. Efficacy of glucagon in acute and healing phase in intact conscious dogs: effects on hemodynamics and myocardial oxygen consumption.
Kumar R; Molokhia FA; Norman JC; Inamdar AN; Messer JV; Abelmann WH; Hood WB; Sharma GV
Circulation; 1972 Jan; 45(1):55-64. PubMed ID: 5007038
[No Abstract] [Full Text] [Related]
15. The effect of glucagon on the coronary circulation in man.
Goldschlager N; Robin E; Cowan CM; Leb G; Bing RJ
Circulation; 1969 Dec; 40(6):829-37. PubMed ID: 5377219
[No Abstract] [Full Text] [Related]
16. The hemodynamic effects of diphenylhydantoin.
Conn RD; Kennedy JW; Blackmon JR
Am Heart J; 1967 Apr; 73(4):500-5. PubMed ID: 6020613
[No Abstract] [Full Text] [Related]
17. Left ventricular performance during the infusion of isoproterenol in patients with valvular heart diseases and idiopathic cardiomegaly.
Ueda H; Machida K; Nakanishi A; Ito I; Yasuda H
Jpn Heart J; 1968 May; 9(3):228-40. PubMed ID: 4235492
[No Abstract] [Full Text] [Related]
18. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
Terry B; White FC; Bloor CM
Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
[No Abstract] [Full Text] [Related]
19. The hemodynamic and metabolic effects of glucagon in patients with chronic valvular heart disease.
Greenberg BH; Tsakiris AG; Moffitt EA; Frye RL
Mayo Clin Proc; 1970 Feb; 45(2):132-9. PubMed ID: 5414174
[No Abstract] [Full Text] [Related]
20. Effect of isoproterenol on coronary blood flow in primary myocardial disease.
Horwitz LD; Curry GC; Parkey RW; Bonte FJ
Circulation; 1974 Sep; 50(3):560-4. PubMed ID: 4606491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
